Cargando…
Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening
Newborn screening (NBS) for Cystic Fibrosis (CF) is associated with improved outcomes. All US states screen for CF; however, CF NBS algorithms have high false positive (FP) rates. In New York State (NYS), the positive predictive value of CF NBS improved from 3.7% to 25.2% following the implementatio...
Autores principales: | Sicko, Robert J., Stevens, Colleen F., Hughes, Erin E., Leisner, Melissa, Ling, Helen, Saavedra-Matiz, Carlos A., Caggana, Michele, Kay, Denise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628990/ https://www.ncbi.nlm.nih.gov/pubmed/34842611 http://dx.doi.org/10.3390/ijns7040073 |
Ejemplares similares
-
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors
por: Kharrazi, Martin, et al.
Publicado: (2022) -
Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018) -
Cystic fibrosis diagnosed by state newborn screening: Or is
it?
por: Fox, Maura, et al.
Publicado: (2020) -
Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California
por: Salinas, Danieli B., et al.
Publicado: (2016) -
Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)